Video’s about Crossing borders in type 2 inflammation

The increasing prevalence of allergic diseases are becoming a major global health concern. These allergic diseases may appear disparate based on their distinct organ and tissue manifestations and are treated as such within our health care systems, respectively by dermatologists, pulmonologists and ENT physicians. A better understanding of type 2 inflammation and treatment modalities is necessary.

However, this fragmentation does not serve the new way of addressing type 2 inflammatory diseases. Focusing on the underlying pathway driving these diseases leads to a better understanding of type 2 inflammation and treatment modalities, giving rise to a new era of personalized therapy.

Dr. Edward Knol, biomedical scientist and immunologist, UMC Utrecht, talks with several experts about this complex subject. You can watch the video's on this page. Create an account or log in with your existing account on this website.


To continue reading, please log in

Log in with your BSL Account

Log in

Forgot your password?

No BSL Account yet? Please register


More information on BSL Accounts.